Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oneview HealthcareASX:ONE 37 Debt-to-Equity is 0.30 as of Dec. 2025, which is 30% above its 10-year median of 0.23. GuruFocus rates ASX:ONE with a GF Score™ of 37/100 and a GF Value™ of A$0.33 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 557 Healthcare Providers & Services companies, Oneview Healthcare ranks better than 59.07% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Oneview Healthcare's Debt-to-Equity or its related term are showing as below:
ASX:ONE'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09 Med: 0.23 Max: 0.37
Current: 0.3
During the past 10 years, the highest Debt-to-Equity Ratio of Oneview Healthcare was 0.37. The lowest was 0.09. And the median was 0.23.
ASX:ONE's Debt-to-Equity is ranked better than 59.07% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs ASX:ONE: 0.30
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Oneview Healthcare Debt-to-Equity Related Terms
Oneview Healthcare Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Oneview Healthcare's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ONE vs VEEV, BTSG, TEM: Debt-to-Equity Comparison
For the Health Information Services subindustry, Oneview Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneview Healthcare Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Oneview Healthcare's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oneview Healthcare (ASX:ONE) has a Debt-to-Equity of 0.30 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Oneview Healthcare and its competitors. This is 30% above median its historical median of 0.23. Over the past decade, Oneview Healthcare's Debt-to-Equity has ranged from 0.09 to 0.37. According to the industry distribution chart, Oneview Healthcare ranks #228 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 40.9%.
Is Oneview Healthcare's Debt-to-Equity too high?
Oneview Healthcare's current Debt-to-Equity of 0.30 is 30% above median its 10-year median of 0.23. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.37. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. Oneview Healthcare's value of 0.30 is 26.8% below this industry median. Based on the distribution chart, Oneview Healthcare ranks #228 out of 557 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Oneview Healthcare has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Oneview Healthcare ranks #228 out of 557 companies for Debt-to-Equity. This puts Oneview Healthcare in the upper half of its industry. The industry median Debt-to-Equity is 0.41. Oneview Healthcare's value of 0.30 is 26.8% below this benchmark. Historically, Oneview Healthcare's own Debt-to-Equity has ranged from 0.09 to 0.37 over the past decade. While the company's 10-year median is 0.23 vs. the industry median of 0.41, Oneview Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oneview Healthcare's current Debt-to-Equity of 0.30 is 26.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Oneview Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneview Healthcare's current Debt-to-Equity is 0.30, which is 30% above median its own 10-year median of 0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.17 — trading 48.5% below its estimated fair value. The current Debt-to-Equity is 0.30, which is 30% above median its 10-year median of 0.23 and 26.8% below the Healthcare Providers & Services industry median of 0.41. Oneview Healthcare's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current Debt-to-Equity is 0.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?
Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued.
The current stock price of A$0.17 is trading 48.5% below its estimated GF Value™ of A$0.33.
GuruFocus considers Oneview Healthcare to be Possible Value Trap.
Key valuation signals for ASX:ONE:
Debt-to-Equity: 0.30 (30% above median its 10-year median of 0.23)
GF Value™: A$0.33 vs. price of A$0.17 (48.5% below fair value)
Industry Position: 26.8% below the Healthcare Providers & Services median (#228 of 557)
No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
37GF Score
Get the complete analysis for ASX:ONE
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ONE has been successfully added to your 
